Olanzapine 5mg orodispersible tablets sugar free
BNF presentation 040201060AAASAS within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040201060AAASAS
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
7,583
NHS spend (£)
£54,053.78
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 1,054 |
| February 2025 | 4 |
| December 2024 | 330 |
| November 2024 | 1,296 |
| October 2024 | 1,259 |
| September 2024 | 6 |
| August 2024 | 101 |
| July 2024 | 1,351 |
| May 2024 | 233 |
| July 2021 | 316 |
| June 2021 | 193 |
| December 2020 | 667 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 70 | No data available |
| Unknown pharmacy | 40 | No data available |
| Unknown pharmacy | 40 | No data available |
| Unknown pharmacy | 39 | No data available |
| Unknown pharmacy | 36 | No data available |
|
Sleaford Medical Group
ODS C83023
|
35 | 71E - LINCOLNSHIRE ICB |
| Unknown pharmacy | 30 | No data available |
| Unknown pharmacy | 30 | No data available |
| Unknown pharmacy | 29 | No data available |
|
Modality Partnership (awc)
ODS B83033
|
28 | 36J - WEST YORKSHIRE ICB |